{"id":"dexamethasone-early","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Immunosuppression/increased infection risk"},{"rate":null,"effect":"Gastrointestinal perforation"},{"rate":null,"effect":"Growth suppression"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Dexamethasone reduces inflammation by inhibiting phospholipase A2, decreasing prostaglandin and leukotriene production, and suppressing cytokine release. In neonates with respiratory distress or chronic lung disease, early administration aims to reduce airway inflammation and improve respiratory outcomes. The 'Early' designation indicates this is an early intervention strategy in the neonatal period.","oneSentence":"Dexamethasone is a synthetic glucocorticoid that suppresses inflammation and immune responses by binding to glucocorticoid receptors.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:09:13.134Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Respiratory distress syndrome in preterm neonates"},{"name":"Chronic lung disease of prematurity (bronchopulmonary dysplasia prevention)"}]},"trialDetails":[{"nctId":"NCT06966700","phase":"PHASE3","title":"A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-06-30","conditions":"Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms","enrollment":2400},{"nctId":"NCT07463807","phase":"PHASE1, PHASE2","title":"Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-06-26","conditions":"Recurrent Multiple Myeloma, Refractory Multiple Myeloma","enrollment":162},{"nctId":"NCT06314334","phase":"PHASE2","title":"Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma","status":"RECRUITING","sponsor":"Fudan University","startDate":"2024-03-04","conditions":"Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type","enrollment":210},{"nctId":"NCT04133636","phase":"PHASE2","title":"A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2019-11-07","conditions":"Multiple Myeloma","enrollment":210},{"nctId":"NCT04181827","phase":"PHASE3","title":"A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2020-06-12","conditions":"Multiple Myeloma","enrollment":419},{"nctId":"NCT06577025","phase":"PHASE2","title":"A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2024-08-20","conditions":"Multiple Myeloma","enrollment":43},{"nctId":"NCT07100990","phase":"PHASE3","title":"Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-07-11","conditions":"Optic Neuritis, Myelitis, Myelitis, Transverse","enrollment":382},{"nctId":"NCT07454226","phase":"NA","title":"ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-03-01","conditions":"Ph-Like, Acute Lymphoblastic Leukemia","enrollment":30},{"nctId":"NCT07442812","phase":"","title":"Oral vs Intravenous Dexamethasone in Total Knee Arthroplasty","status":"NOT_YET_RECRUITING","sponsor":"Haseki Training and Research Hospital","startDate":"2026-03-31","conditions":"Knee Osteoarthritis, Gonarthrosis; Primary, Total Knee Arthroplasty","enrollment":99},{"nctId":"NCT04566328","phase":"PHASE3","title":"Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial","status":"RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2021-02-24","conditions":"Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma, RISS Stage II Plasma Cell Myeloma","enrollment":1450},{"nctId":"NCT06390319","phase":"PHASE2","title":"Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2024-12-27","conditions":"T-cell Acute Lymphoblastic Leukemia, T-cell Lymphoma, Mixed Phenotype Acute Leukemia","enrollment":100},{"nctId":"NCT07337135","phase":"NA","title":"Opioid-Free vs Opioid-Based Anesthesia in Bariatric Surgery","status":"COMPLETED","sponsor":"Hospital dos Lusíadas","startDate":"2023-10-02","conditions":"Morbid Obesity, Postoperative Pain, Opioid Free Anesthesia","enrollment":60},{"nctId":"NCT05440851","phase":"NA","title":"Platform of Randomized Adaptive Clinical Trials in Critical Illness","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2023-04-30","conditions":"Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication, Mechanical Ventilation Pressure High","enrollment":6250},{"nctId":"NCT02776436","phase":"PHASE1","title":"Reducing Dexamethasone Around Docetaxel Infusion","status":"COMPLETED","sponsor":"Leiden University Medical Center","startDate":"2016-01","conditions":"Breast Cancer, Prostate Cancer","enrollment":46},{"nctId":"NCT07411326","phase":"NA","title":"Does Intraoperative Application of Steroids Affect Early Outcomes in Patients Undergoing Endoscopic Lumbar Discectomy?","status":"COMPLETED","sponsor":"Centro Hospitalar De São João, E.P.E.","startDate":"2022-09-10","conditions":"Lumbar Radiculopathy, Lumbar Herniated Disk","enrollment":90},{"nctId":"NCT06533748","phase":"PHASE2","title":"Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2025-01-23","conditions":"Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma","enrollment":128},{"nctId":"NCT04743661","phase":"PHASE2","title":"131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pediatric Brain Tumor Consortium","startDate":"2022-04-04","conditions":"Recurrent Medulloblastoma, Recurrent Ependymoma","enrollment":62},{"nctId":"NCT05070247","phase":"PHASE1, PHASE2","title":"A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors","status":"TERMINATED","sponsor":"Takeda","startDate":"2022-04-14","conditions":"Pancreatic Cancer, Hepatocellular Cancer, Mesothelioma","enrollment":61},{"nctId":"NCT07239817","phase":"NA","title":"PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach","status":"RECRUITING","sponsor":"ASST Gaetano Pini-CTO","startDate":"2025-12-01","conditions":"Hip Fractures, Arthroplasty, Replacement, Hip, Pain, Postoperative","enrollment":100},{"nctId":"NCT03117751","phase":"PHASE2, PHASE3","title":"Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2017-03-29","conditions":"Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma","enrollment":790},{"nctId":"NCT06968559","phase":"PHASE3","title":"Effect of Early Dexamethasone on Major Complications and All-cause Mortality in Severe Burns","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2025-11-07","conditions":"Severe Burns","enrollment":478},{"nctId":"NCT05738486","phase":"PHASE3","title":"A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2023-02-28","conditions":"Alzheimer's Disease, Dementia, Brain Diseases","enrollment":1175},{"nctId":"NCT07168980","phase":"PHASE2, PHASE3","title":"Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents","status":"RECRUITING","sponsor":"Children's Cancer Group, China","startDate":"2025-07-01","conditions":"Mature B-cell Non-Hodgkin Lymphoma","enrollment":87},{"nctId":"NCT00532155","phase":"PHASE3","title":"A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer","status":"COMPLETED","sponsor":"Sanofi","startDate":"2007-09","conditions":"Carcinoma, Non Small Cell Lung","enrollment":913},{"nctId":"NCT03004287","phase":"PHASE2","title":"2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Arkansas","startDate":"2017-07-01","conditions":"Multiple Myeloma","enrollment":50},{"nctId":"NCT04191616","phase":"PHASE2","title":"Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib Triplet","status":"COMPLETED","sponsor":"Amgen","startDate":"2020-08-06","conditions":"Relapsed or Refractory Multiple Myeloma","enrollment":54},{"nctId":"NCT07152041","phase":"PHASE3","title":"Newly-diagnosed Pediatric Ph-positive B-ALL Protocol","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-03-28","conditions":"Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+), Childhood Leukemia, Acute Lymphoblastic","enrollment":150},{"nctId":"NCT06882057","phase":"PHASE2, PHASE3","title":"Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-03-03","conditions":"Acute Lymphoblastic Leukemia ALL, Childhood Leukemia, Acute Lymphoblastic, B Cell Acute Lymphoblastic Leukemia (B-ALL)","enrollment":3000},{"nctId":"NCT06855810","phase":"PHASE2, PHASE3","title":"Newly-diagnosed Pediatric T-cell ALL Protocol","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-03-11","conditions":"Acute Lymphoblastic Leukemia, Childhood Leukemia, Acute Lymphoblastic, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma","enrollment":610},{"nctId":"NCT07109284","phase":"PHASE2","title":"SKB264 Combined With KL-A167 Neoadjuvant Therapy for Early-stage, High-risk ER+/HER2- Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"West China Hospital","startDate":"2025-09","conditions":"ER+HER2- Breast Cancer","enrollment":55},{"nctId":"NCT07060859","phase":"NA","title":"Topical Dexamethasone, Ascorbic Acid, and BGP for Enhancing Implant Osseointegration","status":"COMPLETED","sponsor":"Manar Ziad Foura-Matar","startDate":"2023-01-15","conditions":"Implant Stability and Osseointegration","enrollment":18},{"nctId":"NCT06559553","phase":"PHASE1, PHASE2","title":"\"Selinexor+Pegaspargase+Dexamethasone\"in Ⅰ/Ⅱ NKTCL","status":"RECRUITING","sponsor":"Mingzhi Zhang","startDate":"2024-09-01","conditions":"NKTCL, Selinexor","enrollment":50},{"nctId":"NCT06259006","phase":"PHASE3","title":"TREAT-SC: Early, Short Course Oral Dexamethasone for the Treatment of Sydenham Chorea in Children","status":"RECRUITING","sponsor":"Starship Child Health, Te Toka Tumai Auckland","startDate":"2024-06-17","conditions":"Rheumatic Fever, Sydenham Chorea","enrollment":80},{"nctId":"NCT05253495","phase":"PHASE2","title":"Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma","status":"RECRUITING","sponsor":"New York Medical College","startDate":"2022-02-01","conditions":"Non-hodgkin Lymphoma, Hodgkin Lymphoma","enrollment":80},{"nctId":"NCT05136560","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Early Administration of Dexamethasone in High-risk Sepsis","status":"RECRUITING","sponsor":"CHA University","startDate":"2021-01-15","conditions":"Sepsis","enrollment":102},{"nctId":"NCT06953739","phase":"PHASE3","title":"A Study Comparing of P-GEMD Regimen Versus P-Gemox Regimen With Untreated Early-Stage NUAT or Advanced-Stage ENKTL.","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2025-05-01","conditions":"NK-T-Cell Lymphoma, Extranodal","enrollment":60},{"nctId":"NCT05753046","phase":"PHASE4","title":"Laparoscopic TAP Block During Robotic Assisted Laparoscopic Radical Prostatectomy for Improvement in Postoperative Pain","status":"ENROLLING_BY_INVITATION","sponsor":"Corewell Health East","startDate":"2024-02-19","conditions":"Prostate Cancer","enrollment":94},{"nctId":"NCT05706636","phase":"NA","title":"T Central Memory Cells in Early Localized Non-Segmental Vitiligo","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-02-01","conditions":"Vitiligo","enrollment":22},{"nctId":"NCT05721027","phase":"PHASE4","title":"Ibuprofen With or Without Dexamethasone for Acute Radicular Low Back Pain.","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2023-07-05","conditions":"Radiculopathy, Lumbosacral Region, Back Pain With Radiation, Low Back Pain","enrollment":132},{"nctId":"NCT03643276","phase":"PHASE3","title":"Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017","status":"RECRUITING","sponsor":"Martin Schrappe","startDate":"2018-07-15","conditions":"Acute Lymphoblastic Leukemia, Pediatric","enrollment":5000},{"nctId":"NCT06402279","phase":"","title":"Hemoperfusion Efferon СT for the Extremely Severe Form of COVID-19","status":"COMPLETED","sponsor":"Efferon JSC","startDate":"2020-10-01","conditions":"COVID-19","enrollment":130},{"nctId":"NCT06888349","phase":"NA","title":"The Effect of Combined IPACK Block with ACB Versus ACB Alone on Pain Management and Early Mobility After Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-01-23","conditions":"Postoperative Pain, Motor Activity","enrollment":50},{"nctId":"NCT04513639","phase":"PHASE2, PHASE3","title":"The Relapse from MRD Negativity As Indication for Treatment (REMNANT) Study","status":"RECRUITING","sponsor":"Oslo University Hospital","startDate":"2020-08-27","conditions":"Multiple Myeloma","enrollment":176},{"nctId":"NCT06846073","phase":"NA","title":"Early Combined Use of Dexamethasone Intravitreal Implant and Anti-VEGF in the Treatment of DME.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2024-07-30","conditions":"Diabetic Macular Edema (DME)","enrollment":70},{"nctId":"NCT06361329","phase":"PHASE3","title":"Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL","status":"RECRUITING","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2024-04-03","conditions":"ETP-ALL","enrollment":81},{"nctId":"NCT06764238","phase":"PHASE2, PHASE3","title":"Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-01-03","conditions":"Acute Lymphoblastic Leukemia ALL, Childhood Leukemia, Acute Lymphoblastic, B Cell Acute Lymphoblastic Leukemia (B-ALL)","enrollment":1800},{"nctId":"NCT03839940","phase":"PHASE3","title":"Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer","status":"TERMINATED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2019-06-03","conditions":"Malignant Neoplasm","enrollment":39},{"nctId":"NCT06753500","phase":"PHASE4","title":"Intraoperative Autonomic Blockade for Laparoscopic Cholecystectomy","status":"RECRUITING","sponsor":"Universidad Simón Bolívar","startDate":"2025-01-15","conditions":"Visceral Pain, Analgesia, Opioid Use","enrollment":60},{"nctId":"NCT05895838","phase":"PHASE3","title":"The Danish Out-of-Hospital Cardiac Arrest Study","status":"RECRUITING","sponsor":"Christian Hassager","startDate":"2023-06-16","conditions":"Out-Of-Hospital Cardiac Arrest, Post-Cardiac Arrest Syndrome","enrollment":1000},{"nctId":"NCT03711734","phase":"NA","title":"Acupuncture ACL (Anterior Cruciate Ligament)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2018-11-01","conditions":"ACL, ACL Injury, Anterior Cruciate Ligament Injury","enrollment":40},{"nctId":"NCT06716918","phase":"","title":"Effect of Antenatal Corticosteroids on Neonatal Hypoglycemia","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-01-01","conditions":"Antenatal Corticosteroids","enrollment":188},{"nctId":"NCT05249790","phase":"PHASE3","title":"Anti-inflammatory Drug Algorithm for COVID-19 Home Treatment","status":"WITHDRAWN","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2022-02-24","conditions":"COVID-19","enrollment":""},{"nctId":"NCT04638790","phase":"PHASE3","title":"First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)","status":"RECRUITING","sponsor":"State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia","startDate":"2020-02-01","conditions":"Hodgkin Lymphoma, Adult","enrollment":300},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT04681040","phase":"","title":"Risk Stratification of COVID-19 Using Urine Biomarkers","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Center for Global Health and Medicine, Japan","startDate":"2020-09-15","conditions":"Covid19, Urine, Biomarker","enrollment":964},{"nctId":"NCT03902782","phase":"NA","title":"Erector Spinae Plane Block Versus Intercostal for VATS","status":"COMPLETED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2019-06-26","conditions":"Lung Cancer, Lung Diseases","enrollment":100},{"nctId":"NCT06263530","phase":"","title":"Prognostic Significance of ctDNA in HL","status":"RECRUITING","sponsor":"Interni hematologicka klinika FNKV","startDate":"2022-01-02","conditions":"Prognostic Cancer Model","enrollment":500},{"nctId":"NCT05413642","phase":"PHASE3","title":"COVID-19 Algorithm Treatment at Home","status":"WITHDRAWN","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2023-07-01","conditions":"COVID-19","enrollment":""},{"nctId":"NCT01858922","phase":"PHASE2","title":"Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2012-12-19","conditions":"Hodgkin Disease","enrollment":40},{"nctId":"NCT04381936","phase":"PHASE3","title":"Randomised Evaluation of COVID-19 Therapy","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2020-03-19","conditions":"Severe Acute Respiratory Syndrome","enrollment":70000},{"nctId":"NCT02856438","phase":"","title":"Early Patient Access Treatment Use Protocol CA204-220","status":"NO_LONGER_AVAILABLE","sponsor":"Bristol-Myers Squibb","startDate":"","conditions":"Multiple Myeloma","enrollment":""},{"nctId":"NCT05849857","phase":"PHASE2","title":"Mosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic Countries","status":"RECRUITING","sponsor":"Oslo University Hospital","startDate":"2023-09-11","conditions":"Lymphoma, Follicular","enrollment":80},{"nctId":"NCT05407597","phase":"PHASE2, PHASE3","title":"Inhibition of Bradykinin in COVID-19 Infection With Icatibant","status":"COMPLETED","sponsor":"Belfast Health and Social Care Trust","startDate":"2022-05-16","conditions":"SARS CoV 2 Infection","enrollment":32},{"nctId":"NCT04528329","phase":"PHASE4","title":"Anosmia and / or Ageusia and Early Corticosteroid Use","status":"UNKNOWN","sponsor":"ClinAmygate","startDate":"2021-03-30","conditions":"Covid19, Anosmia","enrollment":300},{"nctId":"NCT04530409","phase":"PHASE4","title":"Timing of Corticosteroids in COVID-19, II. Post COVID-19 Follow-up","status":"UNKNOWN","sponsor":"ClinAmygate","startDate":"2021-03-20","conditions":"Covid19, Corticosteroids","enrollment":752},{"nctId":"NCT01936532","phase":"PHASE2","title":"Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2014-11-12","conditions":"Newly Diagnosed Multiple Myeloma","enrollment":42},{"nctId":"NCT05855395","phase":"NA","title":"The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19","status":"UNKNOWN","sponsor":"Huashan Hospital","startDate":"2023-05-26","conditions":"COVID-19","enrollment":5815},{"nctId":"NCT02623426","phase":"PHASE3","title":"Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial","status":"COMPLETED","sponsor":"JHSPH Center for Clinical Trials","startDate":"2017-03-09","conditions":"Uveitis, Macular Edema","enrollment":194},{"nctId":"NCT02989597","phase":"PHASE4","title":"Intraoperative Methadone Administration for Improved Pain Control in Spinal Fusion Patients","status":"TERMINATED","sponsor":"Montefiore Medical Center","startDate":"2017-07-29","conditions":"Pain, Postoperative","enrollment":10},{"nctId":"NCT05791721","phase":"PHASE4","title":"Effect of Preemptive Etoricoxib and Dexamethasone on Wound Healing and Clinical Parameters After Third Molar Surgery","status":"COMPLETED","sponsor":"University of Belgrade","startDate":"2021-10-11","conditions":"Surgical Wound, Post Operative Pain","enrollment":90},{"nctId":"NCT04854824","phase":"","title":"A Simple Approach to Prevent Hospitalization for COVID-19 Patients","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2021-07-01","conditions":"Covid19","enrollment":216},{"nctId":"NCT05774028","phase":"PHASE2","title":"Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride and Dexamethasone (P-GEMD) in the Treatment of Untreated Early Non-upper Respiratory Tract or Advanced Extranodal NK/T-cell Lymphoma","status":"UNKNOWN","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2023-04","conditions":"NK-T-Cell Lymphoma, Extranodal","enrollment":50},{"nctId":"NCT01298193","phase":"PHASE4","title":"Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer.","status":"COMPLETED","sponsor":"Spanish Breast Cancer Research Group","startDate":"2011-05","conditions":"Breast Cancer","enrollment":212},{"nctId":"NCT05495035","phase":"PHASE1","title":"Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALL","status":"UNKNOWN","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2022-09-01","conditions":"Lymphoblastic Leukemia, Acute, Childhood, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Relapsed Leukemia","enrollment":22},{"nctId":"NCT05293210","phase":"PHASE3","title":"Early Treatment Strategy With High-dose Dexamethasone in Patients With SARS-CoV-2","status":"UNKNOWN","sponsor":"Hospital Universitario Infanta Leonor","startDate":"2023-02-28","conditions":"Covid19, Dexamethasone","enrollment":200},{"nctId":"NCT04836780","phase":"PHASE3","title":"DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia","status":"UNKNOWN","sponsor":"Hospital Universitario Infanta Leonor","startDate":"2021-06-10","conditions":"COVID-19, Acute Respiratory Distress Syndrome, Pneumonia, Viral","enrollment":126},{"nctId":"NCT05658692","phase":"PHASE4","title":"Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-10-01","conditions":"Acute Respiratory Distress Syndrome","enrollment":1000},{"nctId":"NCT05606497","phase":"","title":"OPtimal TIming of COrticosteroids in Early-onset Fetal Growth REstriction: the OPTICORE Study","status":"UNKNOWN","sponsor":"UMC Utrecht","startDate":"2022-05-11","conditions":"Fetal Growth Retardation","enrollment":1800},{"nctId":"NCT05577962","phase":"NA","title":"Opioid Free Anesthesia on the Quality of Early Recovery","status":"UNKNOWN","sponsor":"Beijing Friendship Hospital","startDate":"2023-02-01","conditions":"Opioid-free Anesthesia","enrollment":160},{"nctId":"NCT05558319","phase":"PHASE3","title":"NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide","status":"NOT_YET_RECRUITING","sponsor":"PETHEMA Foundation","startDate":"2022-10","conditions":"Newly Diagnosed Multiple Myeloma","enrollment":480},{"nctId":"NCT04277845","phase":"PHASE2","title":"Randomized Phase II Study in Elderly Patients With Newly Diagnosed Multiple Myeloma","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2020-08-06","conditions":"Multiple Myeloma","enrollment":49},{"nctId":"NCT01782820","phase":"","title":"Influence of a Single Dose Dexamethasone on the Time Course of Neuromuscular Blockade of Rocuronium","status":"COMPLETED","sponsor":"Kreiskrankenhaus Dormagen","startDate":"2011-12","conditions":"Neuromuscular Block, Dexamethasone, Neuromuscular Block, Recovery","enrollment":108},{"nctId":"NCT02075996","phase":"","title":"Non-interventional Study With Pomalidomide (Imnovid®)","status":"COMPLETED","sponsor":"iOMEDICO AG","startDate":"2014-02-11","conditions":"Multiple Myeloma","enrollment":151},{"nctId":"NCT05305404","phase":"EARLY_PHASE1","title":"Dexamethasone to Target Stress and Immune System Mechanisms Underlying Alcohol Craving","status":"UNKNOWN","sponsor":"Stony Brook University","startDate":"2022-03-11","conditions":"Alcohol Use Disorder","enrollment":70},{"nctId":"NCT03950037","phase":"PHASE2","title":"SANCC: Clinical Trial Early Intervention","status":"WITHDRAWN","sponsor":"Oregon Health and Science University","startDate":"2022-01-01","conditions":"Subarachnoid Neurocysticercosis","enrollment":""},{"nctId":"NCT05286008","phase":"NA","title":"Effect of Ultrasound-guided Transversus Abdominis Plane Block After Laparoscopic Bariatric Surgery","status":"UNKNOWN","sponsor":"Tianjin Medical University General Hospital","startDate":"2022-03-18","conditions":"Postoperative Nausea and Vomiting, Postoperative Pain","enrollment":90},{"nctId":"NCT03740880","phase":"NA","title":"Trigger Time in Advanced Maternal Age Patients With Low AMH","status":"TERMINATED","sponsor":"ART Fertility Clinics LLC","startDate":"2019-01-07","conditions":"the Number of Mature Oocytes","enrollment":1},{"nctId":"NCT05258461","phase":"NA","title":"An Innovative Smartphone Application for Adverse Event Management During Breast Cancer Adjuvant Chemotherapy","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2022-03-07","conditions":"Breast Cancer","enrollment":108},{"nctId":"NCT02631239","phase":"PHASE3","title":"MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma","status":"UNKNOWN","sponsor":"Ruijin Hospital","startDate":"2016-03-16","conditions":"Extranodal NK/T-cell Lymphoma, Nasal Type","enrollment":256},{"nctId":"NCT04386395","phase":"","title":"Immune Changes in Severe COVID-19 Pulmonary Infections","status":"COMPLETED","sponsor":"Central Hospital, Nancy, France","startDate":"2020-03-30","conditions":"SARS-CoV-2, Immune System Disorder","enrollment":50},{"nctId":"NCT04935515","phase":"NA","title":"C Reactive Protein in Home Quarantined Coronavirus Disease 2019 (COVID -19) Patients.","status":"COMPLETED","sponsor":"Manimarane Arjunan, MD,DM (Cardiology)","startDate":"2021-04-15","conditions":"COVID -19","enrollment":25},{"nctId":"NCT01326494","phase":"PHASE4","title":"Reducing the Acute Care Burden of Childhood Asthma on Health Services in British Columbia","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2011-04","conditions":"Upper Respiratory Tract Infection, Asthma","enrollment":92},{"nctId":"NCT04856397","phase":"NA","title":"Ozurdex in Suboptimal Diabetic Macular Edema Patients","status":"UNKNOWN","sponsor":"Uptown Eye Specialists","startDate":"2021-05-25","conditions":"Diabetic Macular Edema","enrollment":200},{"nctId":"NCT04746430","phase":"PHASE4","title":"COVID-19 Primary Care Platform for Early Treatment and Recovery (COPPER) Study","status":"TERMINATED","sponsor":"General Practitioners Research Institute","startDate":"2021-02-16","conditions":"Covid19, Corona Virus Infection","enrollment":17},{"nctId":"NCT03440411","phase":"PHASE3","title":"Pom-dex Versus Pom-Cyclo-dex in MM Patients With Biochemical or Clinical Relapse, During Lena Maintenance Treatment","status":"TERMINATED","sponsor":"Fondazione EMN Italy Onlus","startDate":"2016-02-18","conditions":"Multiple Myeloma","enrollment":9},{"nctId":"NCT02897830","phase":"PHASE2","title":"Ixazomib, Lenalidomide, Dexamethasone Induction and Extended Consolidation Plus Lenalidomide Maintenance in Multiple Myeloma","status":"TERMINATED","sponsor":"University Hospital, Toulouse","startDate":"2016-08-05","conditions":"Multiple Myeloma","enrollment":46},{"nctId":"NCT04536558","phase":"PHASE3","title":"Olanzapine Plus Fosaprepitant Standard Antiemetic Therapy in the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients Receiving High Emetic Risk Multi-day Chemotherapy: a Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2020-10-01","conditions":"Solid Tumor Patients Receiving High Emetic Risk Multi-day Chemotherapy","enrollment":352},{"nctId":"NCT04511351","phase":"NA","title":"Radiotherapy Combined With GDP With or Without Chidamide in Stage I/II Extranodal Nasal NK/T-cell Lymphoma","status":"UNKNOWN","sponsor":"Chinese Academy of Medical Sciences","startDate":"2014-08-01","conditions":"Lymphoma","enrollment":76},{"nctId":"NCT02492750","phase":"PHASE1","title":"Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2016-04","conditions":"Indolent Plasma Cell Myeloma, Plasma Cell Myeloma, Smoldering Plasma Cell Myeloma","enrollment":14},{"nctId":"NCT04308525","phase":"","title":"Optimising Microsurgical Reconstruction After Advanced Head and Neck Cancers","status":"UNKNOWN","sponsor":"Rigshospitalet, Denmark","startDate":"2019-06-01","conditions":"Head and Neck Cancer","enrollment":25}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Dexamethasone Early","genericName":"Dexamethasone Early","companyName":"NICHD Neonatal Research Network","companyId":"nichd-neonatal-research-network","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dexamethasone is a synthetic glucocorticoid that suppresses inflammation and immune responses by binding to glucocorticoid receptors. Used for Respiratory distress syndrome in preterm neonates, Chronic lung disease of prematurity (bronchopulmonary dysplasia prevention).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}